The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist

November 5, 2010 7:38 am | by Bio-Medicine.Org | News | Comments

WATERTOWN, Mass., Nov. 5, 2010 /- EnVivo Pharmaceuticals today announced it has discovered that EVP-6124, its alpha-7 nicotinic acetylcholine receptor agonist, possesses a novel mechanism not previously seen in the scientific community: it acts as a co-agonist with Acetylcholine (ACh) to...


Masimo to Present at Lazard Capital Markets 7th Annual Healthcare Conference

November 5, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 5, 2010 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Lazard Capital Markets 7th Annual Healthcare Conference at The St. Regis Hotel in New York on Tuesday, November 16, at 8:55 a.m. ET.  A live audiocast of the...


Daktari Diagnostics raises $1.8M financing

November 5, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Global health firm Daktari Diagnostics Inc., which focuses on delivering diagnostic test results to doctors and patients, has landed $1.8 million in equity financing, according to a filing with the U.S. Securities and Exchange Commission.


Sequenom to Present at Two Financial Conferences in November

November 5, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 5, 2010 /- Sequenom, Inc. (Nasdaq: SQNM ) today announced that company management will present an overview of the company at the following conferences in November. (Logo: ) (Logo:  ...


United American Healthcare Corporation Announces Senior Management Appointments and Relocation to Chicago

November 5, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

DETROIT, Nov. 5, 2010 /- United American Healthcare Corporation (OTCQB: UAHC) today announced that its Board of Directors has approved key appointments to the Company's senior management team.  UAHC management also announced that the Company will relocate its headquarters from...


Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project

November 5, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Nov. 5, 2010 /- Pervasis Therapeutics, Inc. today announced that it has been awarded over $920,000 in grants through the U.S. government's Qualifying Therapeutic Discovery Project, which provides tax credits and grants to projects that show significant potential to...


FDA Approves Cymbalta® for the Management of Chronic Musculoskeletal Pain

November 4, 2010 8:35 pm | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Nov. 4, 2010 /- Eli Lilly and Company (NYSE: LLY ) announced that the U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of chronic musculoskeletal pain. This has been established in studies in patients with chronic low...


Annual CT Lung Screening Saves Lives

November 4, 2010 8:34 pm | by Bio-Medicine.Org | News | Comments

BEVERLY HILLS, Calif., Nov. 4, 2010 /- The physicians of Westside Medical Associates of Los Angeles and Westside Medical Imaging in Beverly Hills , California have announced the results of a pivotal, U.S. government sponsored trial showing that annual screening CT scans save lives....


S & P announces changes to MidCap 400, SmallCap 600

November 4, 2010 5:45 pm | by The Associated Press | News | Comments

Standard & Poor's announced several changes Thursday to its MidCap 400 and SmallCap 600 indices due to acquisitions.S&P said that Bottomline Technologies Inc. will join the SmallCap 600 after trading finishes on Nov. 9, replacing Osteotech Inc., which is being purchased by Medtronic Inc.S&P...

Charles River Laboratories to cut 4 percent of jobs

November 4, 2010 5:37 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Wilmington-based life sciences tools and services company Charles River Laboratories International Inc. will lay off 4 percent of its staff in a move the company said will save $40 million per year. According to recent research with the company claiming 8,500 total employees, the layoffs...


Scripps Research team implicates wayward DNA-repair enzyme in Friedreich's ataxia

November 4, 2010 5:37 pm | by EurekAlert | News | Comments

(Scripps Research Institute) Scripps Research Institute scientists have taken a step closer to understanding the cause of Friedreich's ataxia, a debilitating neurological condition that affects tens of thousands of people worldwide, and so far has no cure.


Genetic deletion discovered as risk factor for autism and schizophrenia

November 4, 2010 5:37 pm | by EurekAlert | News | Comments

(Emory University) Researchers have identified the deletion of a genomic region on chromosome 17 as a significant risk factor for autism spectrum disorders and schizophrenia. A mutation of one of the genes in the deleted interval already is a known cause of renal cysts and diabetes syndrome.


New PinPoint® MEMS gyro - outstanding performance for low budgets

November 4, 2010 5:36 pm | by I-Micronews | News | Comments

This latest device from established MEMS gyro supplier Silicon Sensing is in action at Electronica, November 9 ? 12, 2010 - Hall A2, stand 118.

Screening with low dose CT scans significantly reduces lung cancer deaths

November 4, 2010 5:34 pm | by Diagnostic Imaging | News | Comments

The National Cancer Institute released initial results from a large-scale clinical trial showing lung cancer screening with low-dose CT reduced mortality by 20% when compared to standard chest x-rays.


FDA lowers regulatory hurdle for digital mammography

November 4, 2010 5:33 pm | by Diagnostic Imaging | News | Comments

For the vast majority of medical imaging devices, passing FDA review is a snap: Show equivalence to a device already on the market, wait a few months, and release the announcement that your new product is ready for U.S. patients. But not for full field digital mammography systems.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.